drugset / Trial / NCT07694947
Changes in Eosinophil Cationic Protein and Sputum Eosinophils Following Allergen Immunotherapy
NaSingle-groupOpen-labelTreatment
Summary
Asthma is a chronic heterogeneous inflammatory airway disease affecting millions worldwide and remains a major global health burden. Despite advances in pharmacological therapy, a substantial proportion of patients continue to experience uncontrolled symptoms due to persistent airway inflammation and disease heterogeneity.
Timeline
- Start
- 2023-01-01
- Primary completion
- 2023-07-01
- Completion
- 2024-01-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Allergen Immunotherapy Extract | Vaccine | — | Subcutaneous |